Jackson George L, Edelman David, Weinberger Morris
Durham Veterans Affairs Medical Center, Durham, NC, USA.
J Gen Intern Med. 2006 Oct;21(10):1050-6. doi: 10.1111/j.1525-1497.2006.00519.x.
Guidelines recommend tight control of hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol (LDL-C), and blood pressure (BP) for patients with diabetes. The degree to which these intermediate outcomes are simultaneously controlled has not been extensively described.
Describe the degree of simultaneous control of HbA1c, LDL-C, and BP among Veterans Affairs (VA) diabetes patients defined by both VA and American Diabetes Association (ADA) guidelines.
Cross-sectional cohort.
Eighty-thousand two hundred and seven VA diabetes patients receiving care between October 1999 and September 2000.
We defined simultaneous control of outcomes using 1997 VA Guidelines (in place in 2000) (HbA1c < 9.0%; LDL-C < 130 mg/dL; systolic BP < 140 mmHg; and diastolic BP < 90 mmHg) and 2004 ADA guidelines (HbA1c < 7.0%; LDL-C < 100 mg/dL; systolic BP < 130 mmHg; and diastolic BP < 80 mmHg). A patient is considered to have simultaneous control of the intermediate outcomes for a given definition if the average of measurements for each outcome was below the defined threshold during the study period.
Using VA guidelines, 31% of patients had simultaneous control. Control levels of individual outcomes were: HbA1c (82%), LDL-C (77%), and BP (48%). Using ADA guidelines, 4% had simultaneous control. Control levels of individual outcomes were: HbA1c (36%), LDL-C (41%), and BP (23%). Associations between individual risk factors were weak. There was a modest association between LDL-C control and control of HbA1c (odds ratio [OR] 1.51; 95% confidence interval [CI] 1.44, 1.58). The association between LDL-C and BP control was clinically small (1.26; 1.21, 1.31), and there was an extremely small association between BP and HbA1c control (0.95; 0.92, 0.99). Logistic regression modeling indicates greater body mass index, African American or Hispanic race-ethnicity, and female gender were negatively associated with simultaneous control.
While the proportion of patients who achieved minimal levels of control of HbA1c and LDL-C was high, these data indicate a low level of simultaneous control of HbA1c, LDL-C, and BP among patients with diabetes.
指南建议对糖尿病患者的糖化血红蛋白(HbA1c)、低密度脂蛋白胆固醇(LDL-C)和血压(BP)进行严格控制。这些中间指标同时得到控制的程度尚未得到广泛描述。
描述退伍军人事务部(VA)糖尿病患者中,根据VA和美国糖尿病协会(ADA)指南定义的HbA1c、LDL-C和BP同时得到控制的程度。
横断面队列研究。
1999年10月至2000年9月期间接受治疗的82007名VA糖尿病患者。
我们使用1997年VA指南(2000年有效)(HbA1c < 9.0%;LDL-C < 130 mg/dL;收缩压 < 140 mmHg;舒张压 < 90 mmHg)和2004年ADA指南(HbA1c < 7.0%;LDL-C < 100 mg/dL;收缩压 < 130 mmHg;舒张压 < 80 mmHg)来定义指标的同时控制。如果在研究期间每个指标测量值的平均值低于定义的阈值,则认为患者对于给定定义的中间指标同时得到了控制。
根据VA指南,31%的患者同时得到了控制。各个指标的控制水平分别为:HbA1c(82%)、LDL-C(77%)和BP(48%)。根据ADA指南,4%的患者同时得到了控制。各个指标的控制水平分别为:HbA1c(36%)、LDL-C(41%)和BP(23%)。个体风险因素之间的关联较弱。LDL-C控制与HbA1c控制之间存在适度关联(优势比[OR] 1.51;95%置信区间[CI] 1.44, 1.58)。LDL-C与BP控制之间的关联在临床上较小(1.26;1.21, 1.31),BP与HbA1c控制之间存在极小的关联(0.95;0.92, 0.99)。逻辑回归模型表明,较高的体重指数、非裔美国人或西班牙裔种族以及女性性别与同时控制呈负相关。
虽然达到HbA1c和LDL-C最低控制水平的患者比例较高,但这些数据表明糖尿病患者中HbA1c、LDL-C和BP同时得到控制的水平较低。